MedTrace Logo

Preemptive Analgesia for Primary Dysmenorrhoea

NCT03323671 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2017-12-19

No results posted yet for this study

Summary

Preemptive analgesia before the release of pain mediators

Conditions

  • Primary Dysmenorrhea

Interventions

DRUG

preemptive mefenamic acid

preemptive analgesia before menstrual pain

DRUG

mefenamic acid

mefenamic acid given only during menstruation

Sponsors & Collaborators

  • Hanan Nabil

    lead OTHER

Principal Investigators

  • Hanan Nabil, MD · Manoura University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
25 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2017-12-01
Completion
2017-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03323671 on ClinicalTrials.gov